| Trial ID: | L1630 |
| Source ID: | NCT00573547
|
| Associated Drug: |
Fluoxetine
|
| Title: |
Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Depression
|
| Interventions: |
DRUG: Fluoxetine
|
| Outcome Measures: |
Primary: Determine the efficacy and tolerability of once-weekly fluoxetine in patients with End Stage Renal Disorder who have been diagnosed with depression, Patients will come in for once weekly visits for 12 weeks |
|
| Sponsor/Collaborators: |
Sponsor: Creighton University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2007-02
|
| Completion Date: |
2008-08
|
| Results First Posted: |
|
| Last Update Posted: |
2011-08-16
|
| Locations: |
Creighton Department of Psychiatry, Omaha, Nebraska, 68131, United States|Creighton University Department of Psychiatry, Omaha, Nebraska, 68131, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00573547
|
